CSIMarket



Abbott Laboratories  (ABT)
Other Ticker:  
 
 

ABT's Revenue Growth by Quarter and Year

Abbott Laboratories's Revenue results by quarter and year




ABT Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 11,468.00 10,701.00 8,314.00
III Quarter September - 10,928.00 8,853.00 8,076.00
II Quarter June - 10,223.00 7,328.00 7,979.00
I Quarter March 11,895.00 10,456.00 7,726.00 7,535.00
FY   11,895.00 43,075.00 34,608.00 31,904.00



ABT Revenue first quarter 2022 Y/Y Growth Comment
Abbott Laboratories achieved in the first quarter 2022, above Company average Revenue increase of 13.76% year on year, to $ 11,895.00 millions.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 28 other companies have achieved higher Revenue growth. While Abbott Laboratories' s Revenue growth of 13.76% ranks overall at the positon no. 674 in the first quarter 2022.




ABT Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 7.17 % 28.71 % 7.07 %
III Quarter September - 23.44 % 9.62 % 5.49 %
II Quarter June - 39.51 % -8.16 % 2.73 %
I Quarter March 13.76 % 35.34 % 2.53 % 1.96 %
FY   - 24.47 % 8.48 % 4.34 %

Financial Statements
Abbott Laboratories's first quarter 2022 Revenue $ 11,895.00 millions ABT's Income Statement
Abbott Laboratories's first quarter 2021 Revenue $ 10,456.00 millions Quarterly ABT's Income Statement
New: More ABT's historic Revenue Growth >>


ABT Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 4.94 % 20.87 % 2.95 %
III Quarter September - 6.9 % 20.81 % 1.22 %
II Quarter June - -2.23 % -5.15 % 5.89 %
I Quarter March 3.72 % -2.29 % -7.07 % -2.96 %
FY (Year on Year)   - 24.47 % 8.48 % 4.34 %




Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #29
Healthcare Sector #72
Overall #674

Revenue Y/Y Growth Statistics
High Average Low
42.3 % 6.42 % -47.82 %
(Dec 31 2017)   (Dec 31 2013)
Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #29
Healthcare Sector #72
Overall #674
Revenue Y/Y Growth Statistics
High Average Low
42.3 % 6.42 % -47.82 %
(Dec 31 2017)   (Dec 31 2013)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Abbott Laboratories's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
85.61 % 2.27 % -50.37 %
(June 30. 2012)  


ABT's I. Quarter Q/Q Revenue Comment
Abbott Laboratories achieved in the I. Quarter 2022 above company average sequential Revenue growth of 3.72%, to $ 11,895.00 millions, from $11,468.00 millions in the forth quarter.

Within Major Pharmaceutical Preparations industry 77 other companies have achieved higher Revenue quarter on quarter growth. While Abbott Laboratories's Revenue growth quarter on quarter, overall rank is 1367.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #78
Healthcare Sector #208
Overall #1367
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #78
Healthcare Sector #208
Overall #1367
Revenue Q/Q Growth Statistics
High Average Low
85.61 % 2.27 % -50.37 %
(June 30. 2012)  


ABT's I. Quarter Q/Q Revenue Comment
Abbott Laboratories achieved in the I. Quarter 2022 above company average sequential Revenue growth of 3.72%, to $ 11,895.00 millions, from $11,468.00 millions in the forth quarter.

Within Major Pharmaceutical Preparations industry 77 other companies have achieved higher Revenue quarter on quarter growth. While Abbott Laboratories's Revenue growth quarter on quarter, overall rank is 1367.


Abbott Laboratories's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Revenue 12 Months Ending $ 44,514.00 $ 43,075.00 $ 42,308.00 $ 40,233.00 $ 37,338.00
Y / Y Revenue Growth (TTM) 19.22 % 24.47 % 31.31 % 27.95 % 16.34 %
Year on Year Revenue Growth Overall Ranking # 1641 # 326 # 937 # 896 # 957
Seqeuential Revenue Change (TTM) 3.34 % 1.81 % 5.16 % 7.75 % 7.89 %
Seq. Revenue Growth (TTM) Overall Ranking # 1778 # 1752 # 1549 # 1530 # 953




Cumulative Revenue growth Comment
Assuming the Abbott Laboratories's fiscal year would have ended in Mar 31 2022, Abbott Laboratories would have reprted above average annual Revenue increase of 19.22% year on year, of $ 44,514 millions.
This marks a slow-down of the companys growth trends and from the 24.47% improvement in Dec 31 2021.

In the Healthcare sector 244 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 326 to 1641.

Revenue TTM Q/Q Growth Statistics
High Average Low
8.98 %
0.37 %
-56.84 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 95
Healthcare Sector # 245
Overall # 1641

Revenue TTM Y/Y Growth Statistics
High Average Low
31.35 %
5.98 %
-39.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 95
Sector # 266
S&P 500 # 1778
Cumulative Revenue growth Comment
Assuming the Abbott Laboratories's fiscal year would have ended in Mar 31 2022, Abbott Laboratories would have reprted above average annual Revenue increase of 19.22% year on year, of $ 44,514 millions.
This marks a slow-down of the companys growth trends and from the 24.47% improvement in Dec 31 2021.

In the Healthcare sector 244 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 326 to 1641.

Revenue TTM Q/Q Growth Statistics
High Average Low
8.98 %
0.37 %
-56.84 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 95
Healthcare Sector # 245
Overall # 1641

Revenue TTM Y/Y Growth Statistics
High Average Low
31.35 %
5.98 %
-39.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 95
Sector # 266
S&P 500 # 1778




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ABT's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ABT's Competitors
Revenue Growth for Abbott Laboratories's Suppliers
Revenue Growth for ABT's Customers

You may also want to know
ABT's Annual Growth Rates ABT's Profitability Ratios ABT's Asset Turnover Ratio ABT's Dividend Growth
ABT's Roe ABT's Valuation Ratios ABT's Financial Strength Ratios ABT's Dividend Payout Ratio
ABT's Roa ABT's Inventory Turnover Ratio ABT's Growth Rates ABT's Dividend Comparisons



Companies with similar Revenue improvement for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2022
Optinose Inc 23.41%$ 23.411 millions
Meiragtx Holdings Plc22.59%$ 22.590 millions
Array Technologies Inc 22.22%$ 22.223 millions
Guardant Health Inc 22.16%$ 22.162 millions
United Therapeutics Corporation21.84%$ 21.841 millions
International Stem Cell Corporation21.83%$ 21.834 millions
Vertex Pharmaceuticals Inc21.64%$ 21.643 millions
Incyte Corp21.25%$ 21.252 millions
Venus Concept Inc 20.94%$ 20.941 millions
Catalent Inc 20.86%$ 20.858 millions
Strata Skin Sciences Inc 20.83%$ 20.834 millions
Seaspine Holdings Corporation20.83%$ 20.830 millions
Exact Sciences Corporation20.64%$ 20.645 millions
Option Care Health Inc 20.62%$ 20.619 millions
Penumbra Inc20.50%$ 20.502 millions
Atrion Corporation20.35%$ 20.345 millions
Signify Health Inc 20.28%$ 20.278 millions
Apollo Endosurgery inc 20.24%$ 20.242 millions
Alnylam Pharmaceuticals Inc 20.10%$ 20.101 millions
Lifeloc Technologies Inc 19.40%$ 19.402 millions
Invitae Corporation19.37%$ 19.369 millions
Bio techne Corp19.23%$ 19.225 millions
Amicus Therapeutics inc 18.54%$ 18.543 millions
Ani Pharmaceuticals inc18.26%$ 18.261 millions
Tivity Health Inc 17.97%$ 17.975 millions
Akebia Therapeutics Inc 17.96%$ 17.962 millions
Corcept Therapeutics Inc17.94%$ 17.940 millions
Caredx Inc 17.83%$ 17.828 millions
Castle Biosciences Inc 17.70%$ 17.705 millions
Regenxbio Inc 17.66%$ 17.655 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TESS's Profile

Stock Price

TESS's Financials

Business Description

Fundamentals

Charts & Quotes

TESS's News

Suppliers

TESS's Competitors

Customers & Markets

Economic Indicators

TESS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071